ZOETIS INC. (ZTS)
What changed in recent filings
- Institutions — 6 new · 1 added · 1 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding ZOETIS INC.
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q2: 2 → 2026 Q2: 8 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold ZOETIS INC.
Institutions we track that reported holding this stock in their most recent 13F.
- Bridgewater Associates0.04% of portfolio · since 2022 Q4
- Baillie Gifford & Co0.01% of portfolio · since 2025 Q4
- Tudor Investment CorpNew this quarter0.02% of portfolio · since 2026 Q2
- Soros Fund ManagementNew this quarter0.02% of portfolio · since 2026 Q2
- Moore Capital ManagementNew this quarter0.22% of portfolio · since 2026 Q2
- Blackstoneunder 0.01% of portfolio · held as of 2026 Q2 or earlier
- Caisse de depot (Quebec)0.07% of portfolio · held as of 2026 Q2 or earlier
- National Pension Service (Korea)0.04% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Zoetis. The world's No. 1 in animal medicine. It supplies vaccines and drugs for pets and livestock, maintaining stable growth.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
ZOETIS INC. is classified under the Biotech & Health sector. See peers below.
ZOETIS INC. key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
ZOETIS INC. vs Biotech & Health sector benchmark
Median of 35 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding ZOETIS INC.
Per SEC N-PORT · 2026-06-30 · by weight · factual
ZTS on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
ZTS FAQ
What is ZOETIS INC. (ZTS)?
Zoetis. The world's No. 1 in animal medicine. It supplies vaccines and drugs for pets and livestock, maintaining stable growth.
What sector is ZOETIS INC. in?
ZOETIS INC. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are ZOETIS INC.'s key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 1.5%, Net margin 27.5%, ROE 80.2%, Debt-to-equity 2.87x. Definitions and interpretation are available on Stocklore.
Where can I analyze ZOETIS INC. (ZTS) stock?
On Stocklore you can see ZTS's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.